The DOI matches its Crossref record; 377 of the 377 references it cites were found in a registry or an index.
Antituberculosis drugs: Ten years of research
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
DNA Topoisomerases: Structure, Function, and Mechanism
Champoux, J. J. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.369 · Cited by 2,743
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191
Brennan, P. J., & Nikaido, H. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.000333 · Cited by 1,985
Carter, A. P., Clemons, W. M., Brodersen, D. E., Morgan-Warren, R. J., Wimberly, B. T., & Ramakrishnan, V. (2000) · Nature · doi:10.1038/35030019 · Cited by 1,615
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica, K., & Zhao, X. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.3.377-392.1997 · Cited by 1,494
Ibba, M., & Söll, D. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.617 · Cited by 1,459
inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., & Jacobs, W. R. (1994) · Science · doi:10.1126/science.8284673 · Cited by 1,389
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
Stover, C. K., Warrener, P., VanDevanter, D. R., Sherman, D. R., Arain, T. M., Langhorne, M. H., Anderson, S. W., Towell, J. A., Yuan, Y., McMurray, D. N., et al. (2000) · Nature · doi:10.1038/35016103 · Cited by 1,034
Triclosan targets lipid synthesis
McMurry, L. M., Oethinger, M., & Levy, S. B. (1998) · Nature · doi:10.1038/28970 · Cited by 1,019
Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis
Brennan, P. J. (2003) · Tuberculosis · doi:10.1016/s1472-9792(02)00089-6 · Cited by 884
Platensimycin is a selective FabF inhibitor with potent antibiotic properties
Wang, J., Soisson, S. M., Young, K., Shoop, W., Kodali, S., Galgoci, A., Painter, R., Parthasarathy, G., Tang, Y. S., Cummings, R., et al. (2006) · Nature · doi:10.1038/nature04784 · Cited by 812
Bacterial Topoisomerase Inhibitors: Quinolone and Pyridone Antibacterial Agents
Mitscher, L. A. (2005) · Chemical Reviews · doi:10.1021/cr030101q · Cited by 781
Role of the Major Antigen of Mycobacterium tuberculosis in Cell Wall Biogenesis
Belisle, J. T., Vissa, V. D., Sievert, T., Takayama, K., Brennan, P. J., & Besra, G. S. (1997) · Science · doi:10.1126/science.276.5317.1420 · Cited by 734
Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids
Zheng, C. J., Yoo, J.-S., Lee, T.-G., Cho, H.-Y., Kim, Y.-H., & Kim, W.-G. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.08.028 · Cited by 690
Frieden, T. R., Sterling, T. R., Munsiff, S. S., Watt, C. J., & Dye, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14333-4 · Cited by 689
Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis
Rozwarski, D. A., Grant, G. A., Barton, D. H. R., Jacobs, W. R., & Sacchettini, J. C. (1998) · Science · doi:10.1126/science.279.5347.98 · Cited by 682
Pathway to Synthesis and Processing of Mycolic Acids in Mycobacterium tuberculosis
Takayama, K., Wang, C., & Besra, G. S. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.1.81-101.2005 · Cited by 660
The bacterial ribosome as a target for antibiotics
Poehlsgaard, J., & Douthwaite, S. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1265 · Cited by 607
The Transcriptional Responses of Mycobacterium tuberculosis to Inhibitors of Metabolism
Boshoff, H. I. M., Myers, T. G., Copp, B. R., McNeil, M. R., Wilson, M. A., & Barry, C. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406796200 · Cited by 606
Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv
Camus, J.-C., Pryor, M. J., Médigue, C., & Cole, S. T. (2002) · Microbiology · doi:10.1099/00221287-148-10-2967 · Cited by 597
Protein Kinase G from Pathogenic Mycobacteria Promotes Survival Within Macrophages
Walburger, A., Koul, A., Ferrari, G., Nguyen, L., Prescianotto-Baschong, C., Huygen, K., Klebl, B., Thompson, C., Bacher, G., & Pieters, J. (2004) · Science · doi:10.1126/science.1099384 · Cited by 595
Mycobacterial cell wall: Structure and role in natural resistance to antibiotics
Jarlier, V (1994) · FEMS Microbiology Letters · doi:10.1016/0378-1097(94)90267-4 · Cited by 593
The curious characteristics of pyrazinamide: a review.
Zhang, Y., & Mitchison, D. A. (2003) · PubMed · Cited by 586
Mycolic acids: structure, biosynthesis and physiological functions
Barry, C. E., Lee, R. E., Mdluli, K., Sampson, A. E., Schroeder, B. G., Slayden, R. A., & Yuan, Y. (1998) · Progress in Lipid Research · doi:10.1016/s0163-7827(98)00008-3 · Cited by 565
The Oxazolidinone Linezolid Inhibits Initiation of Protein Synthesis in Bacteria
Swaney, S. M., Aoki, H., Ganoza, M. C., & Shinabarger, D. L. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3251 · Cited by 555
Oxazolidinone Structure–Activity Relationships Leading to Linezolid
Barbachyn, M. R., & Ford, C. W. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200528 · Cited by 553
Function of Lipophilic Acids as Antimicrobial Food Additives
FREESE, E., SHEU, C. W., & GALLIERS, E. (1973) · Nature · doi:10.1038/241321a0 · Cited by 546
Mechanism of Triclosan Inhibition of Bacterial Fatty Acid Synthesis
Heath, R. J., Rubin, J. R., Holland, D. R., Zhang, E., Snow, M. E., & Rock, C. O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.11110 · Cited by 542
M. tuberculosis persistence, latency, and drug tolerance
Gomez, J. E., & McKinney, J. D. (2004) · Tuberculosis · doi:10.1016/j.tube.2003.08.003 · Cited by 533
De Voss, J. J., Rutter, K., Schroeder, B. G., Su, H., Zhu, Y., & Barry, C. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1252 · Cited by 532
Andersson, M. I. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg212 · Cited by 503
Community-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, Peru
Mitnick, C., Bayona, J., Palacios, E., Shin, S., Furin, J., Alcántara, F., Sánchez, E., Sarria, M., Becerra, M., Fawzi, M. C. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022928 · Cited by 489
Mechanisms of latency in Mycobacterium tuberculosis
Parrish, N. M., Dick, J. D., & Bishai, W. R. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(98)01216-5 · Cited by 483
Bacterial Fatty Acid Biosynthesis: Targets for Antibacterial Drug Discovery
Campbell, J. W., & Cronan, J. E. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.305 · Cited by 479
Lambert, P. A. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.7.x · Cited by 450
Synthesis and Antimycobacterial Activity of Pyrazine and Quinoxaline Derivatives
Seitz, L. E., Suling, W. J., & Reynolds, R. C. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020310n · Cited by 441
Wagner, D., Maser, J., Lai, B., Cai, Z., Barry, C. E., Höner zu Bentrup, K., Russell, D. G., & Bermudez, L. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1491 · Cited by 435
THE MAGIC BULLETS AND TUBERCULOSIS DRUG TARGETS
Zhang, Y. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.100120 · Cited by 432
Birmingham, M. C., Rayner, C. R., Meagher, A. K., Flavin, S. M., Batts, D. H., & Schentag, J. J. (2003) · Clinical Infectious Diseases · doi:10.1086/345744 · Cited by 428
Structure, Molecular Mechanisms, and Evolutionary Relationships in DNA Topoisomerases
Corbett, K. D., & Berger, J. M. (2004) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.33.110502.140357 · Cited by 426
Mechanisms of action of isoniazid
Timmins, G. S., & Deretic, V. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05467.x · Cited by 421
Fluoroquinolones, tuberculosis, and resistance
Ginsburg, A. S., Grosset, J. H., & Bishai, W. R. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00671-6 · Cited by 403
Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection
Tufariello, J. M., Chan, J., & Flynn, J. L. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00741-2 · Cited by 403
The eukaryotic-like Ser/Thr protein kinases of Mycobacterium tuberculosis
Av-Gay, Y., & Everett, M. (2000) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01734-0 · Cited by 378
Protopopova, M., Hanrahan, C., Nikonenko, B., Samala, R., Chen, P., Gearhart, J., Einck, L., & Nacy, C. A. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki319 · Cited by 371
Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis
Takayama, K., & Kilburn, J. O. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1493 · Cited by 369
Interplay between mycobacteria and host signalling pathways
Koul, A., Herget, T., Klebl, B., & Ullrich, A. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro840 · Cited by 365
A Critical Review of the Fluoroquinolones: Focus on Respiratory Infections
Zhanel, G. G., Ennis, K., Vercaigne, L., Walkty, A., Gin, A. S., Embil, J., Smith, H., & Hoban, D. J. (2002) · Drugs · doi:10.2165/00003495-200262010-00002 · Cited by 344
Iron, mycobacteria and tuberculosis
Ratledge, C. (2004) · Tuberculosis · doi:10.1016/j.tube.2003.08.012 · Cited by 344
Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis
DeBarber, A. E., Mdluli, K., Bosman, M., Bekker, L.-G., & Barry, C. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9677 · Cited by 338
Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis
Chan, E. D., Laurel, V., Strand, M. J., Chan, J. F., Huynh, M.-L. N., Goble, M., & Iseman, M. D. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200308-1159oc · Cited by 336
Ramaswamy, S. V., Reich, R., Dou, S.-J., Jasperse, L., Pan, X., Wanger, A., Quitugua, T., & Graviss, E. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1241-1250.2003 · Cited by 336
Inhibition of β-Ketoacyl-Acyl Carrier Protein Synthases by Thiolactomycin and Cerulenin
Price, A. C., Choi, K.-H., Heath, R. J., Li, Z., White, S. W., & Rock, C. O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007101200 · Cited by 335
Programmes and principles in treatment of multidrug-resistant tuberculosis
Mukherjee, J. S., Rich, M. L., Socci, A. R., Joseph, J. K., Virú, F. A., Shin, S. S., Furin, J. J., Becerra, M. C., Barry, D. J., Kim, J. Y., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15496-2 · Cited by 333
Manjunatha, U. H., Boshoff, H., Dowd, C. S., Zhang, L., Albert, T. J., Norton, J. E., Daniels, L., Dick, T., Pang, S. S., & Barry, C. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508392103 · Cited by 331
Heym, B., Alzari, P. M., Honore, N., & Cole, S. T. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02238.x · Cited by 330
Adverse reactions to first-line antituberculosis drugs
Forget, E. J., & Menzies, D. (2006) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.2.231 · Cited by 315
Baker, S. J., Zhang, Y.-K., Akama, T., Lau, A., Zhou, H., Hernandez, V., Mao, W., Alley, M. R. K., Sanders, V., & Plattner, J. J. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0603724 · Cited by 314
Activation of the Pro-drug Ethionamide Is Regulated in Mycobacteria
Baulard, A. R., Betts, J. C., Engohang-Ndong, J., Quan, S., McAdam, R. A., Brennan, P. J., Locht, C., & Besra, G. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003744200 · Cited by 311
Lenaerts, A. J., Gruppo, V., Marietta, K. S., Johnson, C. M., Driscoll, D. K., Tompkins, N. M., Rose, J. D., Reynolds, R. C., & Orme, I. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2294-2301.2005 · Cited by 306
Biogenesis of the mycobacterial cell wall and the site of action of ethambutol
Mikusová, K., Slayden, R. A., Besra, G. S., & Brennan, P. J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2484 · Cited by 301
FtsZ, a prokaryotic homolog of tubulin?
Erickson, H. P. (1995) · Cell · doi:10.1016/0092-8674(95)90486-7 · Cited by 300
Biosynthesis of the arabinogalactan-peptidoglycan complex of Mycobacterium tuberculosis
Crick, D. C., Mahapatra, S., & Brennan, P. J. (2001) · Glycobiology · doi:10.1093/glycob/11.9.107r · Cited by 293
Ferreras, J. A., Ryu, J.-S., Di Lello, F., Tan, D. S., & Quadri, L. E. N. (2005) · Nature Chemical Biology · doi:10.1038/nchembio706 · Cited by 293
Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs
Weinstein, E. A., Yano, T., Li, L.-S., Avarbock, D., Avarbock, A., Helm, D., McColm, A. A., Duncan, K., Lonsdale, J. T., & Rubin, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500469102 · Cited by 289
ethA , inhA , and katG Loci of Ethionamide-Resistant Clinical Mycobacterium tuberculosis Isolates
Morlock, G. P., Metchock, B., Sikes, D., Crawford, J. T., & Cooksey, R. C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3799-3805.2003 · Cited by 288
Zhang, Y., Scorpio, A., Nikaido, H., & Sun, Z. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.7.2044-2049.1999 · Cited by 285
The ATP-Binding Site of Type II Topoisomerases as a Target for Antibacterial Drugs
Maxwell, A., & Lawson, D. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452500 · Cited by 277
Maus, C. E., Plikaytis, B. B., & Shinnick, T. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3192-3197.2005 · Cited by 273
Wolucka, B. A., McNeil, M. R., de Hoffmann, E., Chojnacki, T., & Brennan, P. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31657-5 · Cited by 272
Zimhony, O., Cox, J. S., Welch, J. T., Vilchèze, C., & Jacobs, W. R. (2000) · Nature Medicine · doi:10.1038/79558 · Cited by 270
Worldwide Incidence of Multidrug‐Resistant Tuberculosis
Dye, C., Espinal, M. A., Watt, C. J., Mbiaga, C., & Williams, B. G. (2002) · The Journal of Infectious Diseases · doi:10.1086/339818 · Cited by 269
Iron Acquisition and Metabolism by Mycobacteria
De Voss, J. J., Rutter, K., Schroeder, B. G., & Barry, C. E. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.15.4443-4451.1999 · Cited by 268
Jackson, M., Raynaud, C., Lanéelle, M., Guilhot, C., Laurent‐Winter, C., Ensergueix, D., Gicquel, B., & Daffé, M. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01310.x · Cited by 267
Targeting Tuberculosis and Malaria through Inhibition of Enoyl Reductase
Kuo, M. R., Morbidoni, H. R., Alland, D., Sneddon, S. F., Gourlie, B. B., Staveski, M. M., Leonard, M., Gregory, J. S., Janjigian, A. D., Yee, C., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211968200 · Cited by 263
The Methyl-Branched Fortifications of Mycobacterium tuberculosis
Minnikin, D. E., Kremer, L., Dover, L. G., & Besra, G. S. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00142-4 · Cited by 262
He, X., Alian, A., Stroud, R., & Ortiz de Montellano, P. R. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060715y · Cited by 257
Kremer, L., Douglas, J. D., Baulard, A. R., Morehouse, C., Guy, M. R., Alland, D., Dover, L. G., Lakey, J. H., Jacobs, W. R., Brennan, P. J., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000569200 · Cited by 256
The Treatment of Multidrug-Resistant Tuberculosis in Turkey
Tahaoğlu, K., Törün, T., Sevim, T., Ataç, G., Kir, A., Karasulu, L., Özmen, İ., & Kapaklı, N. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450303 · Cited by 248
Peripheral neuropathy associated with prolonged use of linezolid
Bressler, A. M., Zimmer, S. M., Gilmore, J. L., & Somani, J. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01109-0 · Cited by 246
Johansen, S. K., Maus, C. E., Plikaytis, B. B., & Douthwaite, S. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.044 · Cited by 244
Heath, R. J., Li, J., Roland, G. E., & Rock, C. O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.4654 · Cited by 240
Tuberculosis control in the era of HIV
Nunn, P., Williams, B., Floyd, K., Dye, C., Elzinga, G., & Raviglione, M. (2005) · Nature Reviews Immunology · doi:10.1038/nri1704 · Cited by 240
Aubry, A., Pan, X.-S., Fisher, L. M., Jarlier, V., & Cambau, E. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1281-1288.2004 · Cited by 240
Schlünzen, F., Pyetan, E., Fucini, P., Yonath, A., & Harms, J. M. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04346.x · Cited by 240
A Mechanism of Drug Action Revealed by Structural Studies of Enoyl Reductase
Baldock, C., Rafferty, J. B., Sedelnikova, S. E., Baker, P. J., Stuitje, A. R., Slabas, A. R., Hawkes, T. R., & Rice, D. W. (1996) · Science · doi:10.1126/science.274.5295.2107 · Cited by 239
Somu, R. V., Boshoff, H., Qiao, C., Bennett, E. M., Barry, C. E., & Aldrich, C. C. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051060o · Cited by 238
Inhibition of InhA, the Enoyl Reductase from Mycobacterium tuberculosis, by Triclosan and Isoniazid
Parikh, S. L., Xiao, G., & Tonge, P. J. (2000) · Biochemistry · doi:10.1021/bi0008940 · Cited by 238
Sullivan, T. J., Truglio, J. J., Boyne, M. E., Novichenok, P., Zhang, X., Stratton, C. F., Li, H.-J., Kaur, T., Amin, A., Johnson, F., et al. (2006) · ACS Chemical Biology · doi:10.1021/cb0500042 · Cited by 236
Singh, S. B., Jayasuriya, H., Ondeyka, J. G., Herath, K. B., Zhang, C., Zink, D. L., Tsou, N. N., Ball, R. G., Basilio, A., Genilloud, O., et al. (2006) · Journal of the American Chemical Society · doi:10.1021/ja062232p · Cited by 232
The Antituberculosis Drug Ethionamide Is Activated by a Flavoprotein Monooxygenase
Vannelli, T. A., Dykman, A., & Ortiz de Montellano, P. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110751200 · Cited by 232
Pharmacodynamics and pharmacokinetics of SQ109, a new diamine‐based antitubercular drug
Jia, L., Tomaszewski, J. E., Hanrahan, C., Coward, L., Noker, P., Gorman, G., Nikonenko, B., & Protopopova, M. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705984 · Cited by 231
Molecular Mechanisms of Multiple Drug Resistance in Clinical Isolates of Mycobacterium tuberculosis
Morris, S., Bai, G. H., Suffys, P., Portillo-Gomez, L., Fairchok, M., & Rouse, D. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.4.954 · Cited by 231
Antibiotic Activity and Characterization of BB-3497, a Novel Peptide Deformylase Inhibitor
Clements, J. M., Beckett, R. P., Brown, A., Catlin, G., Lobell, M., Palan, S., Thomas, W., Whittaker, M., Wood, S., Salama, S., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.563-570.2001 · Cited by 230
Young, T. A., Delagoutte, B., Endrizzi, J. A., Falick, A. M., & Alber, T. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb897 · Cited by 229
Antimycobacterial natural products
Copp, B. R. (2003) · Natural Product Reports · doi:10.1039/b212154a · Cited by 228
Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases
Reeves, P. M., Bommarius, B., Lebeis, S., McNulty, S., Christensen, J., Swimm, A., Chahroudi, A., Chavan, R., Feinberg, M. B., Veach, D., et al. (2005) · Nature Medicine · doi:10.1038/nm1265 · Cited by 226
Linezolid for the treatment of multidrug-resistant tuberculosis
Fortún, J., Martín-Dávila, P., Navas, E., Pérez-Elías, M. J., Cobo, J., Tato, M., De la Pedrosa, E. G.-G., Gómez-Mampaso, E., & Moreno, S. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki148 · Cited by 225
Cell Wall Core Galactofuran Synthesis Is Essential for Growth of Mycobacteria
Pan, F., Jackson, M., Ma, Y., & McNeil, M. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.13.3991-3998.2001 · Cited by 225
Search for New Drugs for Treatment of Tuberculosis
Program*, T. D. S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.1943-1946.2001 · Cited by 223
Bramhill, D. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.395 · Cited by 223
Zhang, Y.-M., & Rock, C. O. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403697200 · Cited by 222
Mycobacterial porins – new channel proteins in unique outer membranes
Niederweis, M. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03662.x · Cited by 221
Freiberg, C., Brunner, N. A., Schiffer, G., Lampe, T., Pohlmann, J., Brands, M., Raabe, M., Häbich, D., & Ziegelbauer, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402989200 · Cited by 218
Studies on the Mechanism of Action of Isoniazid and Ethionamide in the Chemotherapy of Tuberculosis
Johnsson, K., King, D. S., & Schultz, P. G. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00122a038 · Cited by 215
Perozzo, R., Kuo, M., Sidhu, A. B. S., Valiyaveettil, J. T., Bittman, R., Jacobs, W. R., Fidock, D. A., & Sacchettini, J. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112000200 · Cited by 213
Mechanism of action of the oxazolidinone antibacterial agents
Shinabarger, D. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.8.1195 · Cited by 211
Action Mechanism of Antitubercular Isoniazid
Lei, B., Wei, C.-J., & Tu, S.-C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2520 · Cited by 208
Lee, R. E., Protopopova, M., Crooks, E., Slayden, R. A., Terrot, M., & Barry, C. E. (2003) · Journal of Combinatorial Chemistry · doi:10.1021/cc020071p · Cited by 207
In Vitro and In Vivo Activities of Macrolide Derivatives against Mycobacterium tuberculosis
Falzari, K., Zhu, Z., Pan, D., Liu, H., Hongmanee, P., & Franzblau, S. G. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1447-1454.2005 · Cited by 207
Margalit, D. N., Romberg, L., Mets, R. B., Hebert, A. M., Mitchison, T. J., Kirschner, M. W., & RayChaudhuri, D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404439101 · Cited by 206
The Trojan horse: survival tactics of pathogenic mycobacteria in macrophages
Nguyen, L., & Pieters, J. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.03.009 · Cited by 206
Prospects for Aminoacyl-tRNA Synthetase Inhibitors as New Antimicrobial Agents
Hurdle, J. G., O'Neill, A. J., & Chopra, I. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.4821-4833.2005 · Cited by 203
Nakama, T., Nureki, O., & Yokoyama, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m109089200 · Cited by 200
Wang, J., Galgoci, A., Kodali, S., Herath, K. B., Jayasuriya, H., Dorso, K., Vicente, F., González, A., Cully, D., Bramhill, D., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307625200 · Cited by 200
Brandish, P. E., Kimura, K. I., Inukai, M., Southgate, R., Lonsdale, J. T., & Bugg, T. D. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.7.1640 · Cited by 199
Aubry, A., Veziris, N., Cambau, E., Truffot-Pernot, C., Jarlier, V., & Fisher, L. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.104-112.2006 · Cited by 197
Tasdemir, D., Lack, G., Brun, R., Rüedi, P., Scapozza, L., & Perozzo, R. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0600545 · Cited by 196
Persistent and dormant tubercle bacilli and latent tuberculosis
Zhang, Y. (2004) · Frontiers in Bioscience · doi:10.2741/1291 · Cited by 195
Crystal Structures of Mycolic Acid Cyclopropane Synthases from Mycobacterium tuberculosis
Huang, C.-C., Smith, C. V., Glickman, M. S., Jacobs, W. R., & Sacchettini, J. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111698200 · Cited by 191
The Ser/Thr Protein Kinase PknB Is Essential for Sustaining Mycobacterial Growth
Fernandez, P., Saint-Joanis, B., Barilone, N., Jackson, M., Gicquel, B., Cole, S. T., & Alzari, P. M. (2006) · Journal of Bacteriology · doi:10.1128/jb.00963-06 · Cited by 190
Hu, Y., Coates, A. R. M., & Mitchison, D. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.653-657.2003 · Cited by 187
The Diagnosis and Therapy of Tuberculosis During the Past 100 Years
Mitchison, D. A. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200411-1603oe · Cited by 185
Tenson, T., & Mankin, A. S. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05063.x · Cited by 184
Hippocampus-dependent learning facilitated by a monoclonal antibody or D-cycloserine
Thompson, L. T., Moskal, J. R., & Disterhoft, J. F. (1992) · Nature · doi:10.1038/359638a0 · Cited by 182
Drugs that Inhibit Mycolic Acid Biosynthesis in Mycobacterium tuberculosis
SCHROEDER, E., de Souza, O. N., dos Santos, D. K. C., Blanchard, J. S., & Basso, L. A. (2002) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023378328 · Cited by 181
Cloning and Characterization of Secretory Tyrosine Phosphatases of Mycobacterium tuberculosis
Koul, A., Choidas, A., Treder, M., Tyagi, A. K., Drlica, K., Singh, Y., & Ullrich, A. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.19.5425-5432.2000 · Cited by 181
Poulsen, S. M., Karlsson, M., Johansson, L. B., & Vester, B. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02595.x · Cited by 179
Translation and Protein Synthesis: Macrolides
Katz, L., & Ashley, G. W. (2005) · Chemical Reviews · doi:10.1021/cr030107f · Cited by 177
Sacchettini, J. C., Ronning, D. R., Klabunde, T., Besra, G. S., Vissa, V., & Belisle, J. T. (2000) · Nature Structural Biology · doi:10.1038/72413 · Cited by 177
New Small-Molecule Synthetic Antimycobacterials
Ballell, L., Field, R. A., Duncan, K., & Young, R. J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2153-2163.2005 · Cited by 177
Cell walls of mycobacteria and related organisms; Chemistry and immunostimulant properties
LEDERER, E., Adam, A., Barot-Ciorbaru, R., Petit, J. F., & Wietzerbin, J. (1975) · Molecular and Cellular Biochemistry · doi:10.1007/bf01792076 · Cited by 176
Babaoglu, K., Page, M. A., Jones, V. C., McNeil, M. R., Dong, C., Naismith, J. H., & Lee, R. E. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00673-5 · Cited by 175
Structural basis for selectivity and toxicity of ribosomal antibiotics
Böttger, E. C., Springer, B., Prammananan, T., Kidan, Y. G., & Sander, P. (2001) · EMBO Reports · doi:10.1093/embo-reports/kve062 · Cited by 175
Rengarajan, J., Sassetti, C. M., Naroditskaya, V., Sloutsky, A., Bloom, B. R., & Rubin, E. J. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04120.x · Cited by 174
McLean, K. J., Marshall, K. R., Richmond, A., Hunter, I. S., Fowler, K., Kieser, T., Gurcha, S. S., Besra, G. S., & Munro, A. W. (2002) · Microbiology · doi:10.1099/00221287-148-10-2937 · Cited by 174
Discovery of a Novel and Potent Class of FabI-Directed Antibacterial Agents
Payne, D. J., Miller, W. H., Berry, V., Brosky, J., Burgess, W. J., Chen, E., DeWolf, W. E., Fosberry, A. P., Greenwood, R., Head, M. S., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3118-3124.2002 · Cited by 170
2-Deoxystreptamine: Central Scaffold of Aminoglycoside Antibiotics
Busscher, G. F., Rutjes, F. P. J. T., & van Delft, F. L. (2005) · Chemical Reviews · doi:10.1021/cr0404085 · Cited by 169
Inhibitors of branched-chain amino acid biosynthesis as potential antituberculosis agents
Grandoni, J. A., Marta, P. T., & Schloss, J. V. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.4.475 · Cited by 168
Gundersen, L.-L., Charnock, C., Negussie, A. H., Rise, F., & Teklu, S. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.09.006 · Cited by 167
Hilliard, J. J., Goldschmidt, R. M., Licata, L., Baum, E. Z., & Bush, K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1693 · Cited by 167
Unique Mechanism of Action of the Thiourea Drug Isoxyl on Mycobacterium tuberculosis
Phetsuksiri, B., Jackson, M., Scherman, H., McNeil, M., Besra, G. S., Baulard, A. R., Slayden, R. A., DeBarber, A. E., Barry, C. E., Baird, M. S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m311209200 · Cited by 167
Palermo, C. M., Westlake, C. A., & Gasiewicz, T. A. (2005) · Biochemistry · doi:10.1021/bi047433p · Cited by 166
LEA3D: A Computer-Aided Ligand Design for Structure-Based Drug Design
Douguet, D., Munier-Lehmann, H., Labesse, G., & Pochet, S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0492296 · Cited by 165
Chen, P. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl227 · Cited by 164
Aminoacyl tRNA synthetases as targets for new anti‐infectives
Schimmel, P., Tao, J., & Hill, J. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.15.1599 · Cited by 163
Indole Naphthyridinones as Inhibitors of Bacterial Enoyl-ACP Reductases FabI and FabK
Seefeld, M. A., Miller, W. H., Newlander, K. A., Burgess, W. J., DeWolf, W. E., Elkins, P. A., Head, M. S., Jakas, D. R., Janson, C. A., Keller, P. M., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0204035 · Cited by 163
Alderwick, L. J., Seidel, M., Sahm, H., Besra, G. S., & Eggeling, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600045200 · Cited by 162
Ward, W. H. J., Holdgate, G. A., Rowsell, S., McLean, E. G., Pauptit, R. A., Clayton, E., Nichols, W. W., Colls, J. G., Minshull, C. A., Jude, D. A., et al. (1999) · Biochemistry · doi:10.1021/bi9907779 · Cited by 161
Rouse, D. A., Li, Z., Bai, G. H., & Morris, S. L. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2472 · Cited by 160
Ryll, R., Kumazawa, Y., & Yano, I. (2001) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2001.tb01319.x · Cited by 159
Synthesis and in vitro and in vivo antimycobacterial activity of isonicotinoyl hydrazones
Sriram, D., Yogeeswari, P., & Madhu, K. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.07.011 · Cited by 159
Deidda, D., Lampis, G., Fioravanti, R., Biava, M., Porretta, G. C., Zanetti, S., & Pompei, R. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.3035 · Cited by 159
Ortiz-Lombardı́a, M., Pompeo, F., Boitel, B., & Alzari, P. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300660200 · Cited by 158
Antimycobacterial action of thiolactomycin: an inhibitor of fatty acid and mycolic acid synthesis
Slayden, R. A., Lee, R. E., Jr., Armour, J. W., Cooper, A. M., Orme, I. M., Brennan, P. J., & Besra, G. S. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.12.2813 · Cited by 158
Recognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelope
Deng, L. L., Mikušová, K., Robuck, K. G., Scherman, M., Brennan, P. J., & McNeil, M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.694 · Cited by 157
Fatty acid biosynthesis as a target for novel antibacterials.
Heath, R. J., & Rock, C. O. (2004) · PubMed · Cited by 156
NAD+-dependent DNA Ligase (Rv3014c) from Mycobacterium tuberculosis
Srivastava, S. K., Tripathi, R. P., & Ramachandran, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503780200 · Cited by 156
History of Quinolones and Their Side Effects
Rubinstein, E. (2001) · Chemotherapy · doi:10.1159/000057838 · Cited by 153
Ma, Y., Stern, R. J., Scherman, M. S., Vissa, V., Yan, W., Jones, V. C., Zhang, F., Franzblau, S. G., Lewis, W. H., & McNeil, M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1407-1416.2001 · Cited by 153
Boshoff, H. I., Mizrahi, V., & Barry, C. E. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.8.2167-2172.2002 · Cited by 152
Aspartyl-tRNA Synthetase Is the Target of Peptide Nucleotide Antibiotic Microcin C
Metlitskaya, A. Z., Kazakov, T., Kommer, A., Pavlova, O., Prætorius-Ibba, M., Ibba, M., Krasheninnikov, I. A., Kolb, V. A., Khmel, I. A., & Severinov, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513174200 · Cited by 151
Flux Balance Analysis of Mycolic Acid Pathway: Targets for Anti-Tubercular Drugs
Raman, K., Rajagopalan, P., & Chandra, N. R. (2005) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0010046 · Cited by 149
Novel targets for tuberculosis drug discovery
Mdluli, K. E., & Spigelman, M. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.06.004 · Cited by 149
Mycobacterial lipoarabinomannans: modulators of dendritic cell function and the apoptotic response
Nigou, J., Gilleron, M., Rojas, M., García, L. F., Thurnher, M., & Puzo, G. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01621-0 · Cited by 149
Leys, D., Mowat, C. G., McLean, K. J., Richmond, A., Chapman, S. K., Walkinshaw, M. D., & Munro, A. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209928200 · Cited by 144
Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)—a report of ten cases
von der Lippe, B., Sandven, P., & Brubakk, O. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.04.007 · Cited by 142
Oxazolidinone Antibacterial Agents: A Critical Review
Hutchinson, D. K. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452195 · Cited by 142
Silva, P. E. A., Bigi, F., Santangelo, M. D. L. P., Romano, M. I., Martín, C., Cataldi, A. A., & Aínsa, J. A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.800-804.2001 · Cited by 141
Cross-linking in the living cell locates the site of action of oxazolidinone antibiotics
Colca, J. R., McDonald, W. G., Waldon, D. J., Thomasco, L. M., Gadwood, R. C., Lund, E. T., Cavey, G. S., Mathews, W. R., Adams, L. D., Cecil, E. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302109200 · Cited by 139
Oxazolidinone Antibiotics Target the P Site onEscherichiacoliRibosomes
Aoki, H., Ke, L., Poppe, S. M., Poel, T. J., Weaver, E. A., Gadwood, R. C., Thomas, R. C., Shinabarger, D. L., & GANOZA, M. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1080-1085.2002 · Cited by 139
Translation and Protein Synthesis: Macrolides
Katz, L., & Ashley, G. W. (2005) · ChemInform · doi:10.1002/chin.200524271 · Cited by 138
Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs
Barry, C. E., Slayden, R. A., Sampson, A. E., & Lee, R. E., Jr. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00253-1 · Cited by 136
Feng, Z., & Barletta, R. G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.283-291.2003 · Cited by 136
Histidine kinases as targets for new antimicrobial agents
Matsushita, M., & Janda, K. D. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00355-8 · Cited by 135
Synthesis and anti-tubercular evaluation of 4-quinolylhydrazones
Savini, L., Chiasserini, L., Gaeta, A., & Pellerano, C. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00071-8 · Cited by 134
Mycobacterium tuberculosis Cells Growing in Macrophages Are Filamentous and Deficient in FtsZ Rings
Chauhan, A., Madiraju, M. V. V. S., Fol, M., Lofton, H., Maloney, E., Reynolds, R., & Rajagopalan, M. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.5.1856-1865.2006 · Cited by 132
The synthesis and SAR of rhodanines as novel class C β-lactamase inhibitors
Grant, E. B., Guiadeen, D., Baum, E. Z., Foleno, B. D., Jin, H., Montenegro, D. A., Nelson, E. A., Bush, K., & Hlasta, D. J. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00444-3 · Cited by 132
Engineered Biosynthesis of Geldanamycin Analogs for Hsp90 Inhibition
Patel, K. G., Piagentini, M., Rascher, A., Tian, Z., Buchanan, G. O., Regentin, R., Hu, Z., Hutchinson, C. R., & McDaniel, R. N. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.09.012 · Cited by 131
Mycobacterium tuberculosis dihydrofolate reductase is a target for isoniazid
Argyrou, A., Vetting, M. W., Aladegbami, B. G., & Blanchard, J. S. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1089 · Cited by 131
Payton, M. A., Auty, R., Delgoda, R., Everett, M. J., & Sim, E. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.4.1343-1347.1999 · Cited by 131
Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?
Perri, G. D., & Bonora, S. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh377 · Cited by 130
Hearn, M. J. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh041 · Cited by 130
Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-Oxide derivatives
Zarranz, B., Jaso, A., Aldana, I., & Monge, A. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(03)00119-6 · Cited by 128
Chlorpromazine: A Drug Potentially Useful for Treating Mycobacterial Infections
Crowle, A. J., Douvas, G. S., & May, M. H. (2009) · Chemotherapy · doi:10.1159/000239036 · Cited by 128
Prospects for Clinical Introduction of Nitroimidazole Antibiotics for the Treatment of Tuberculosis
Barry, C. E., Boshoff, H. I., & Dowd, C. S. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383214 · Cited by 128
Preparation and antibacterial activities of new 1,2,3-diazaborine derivatives and analogs
Grassberger, M. A., Turnowsky, F., & Hildebrandt, J. (1984) · Journal of Medicinal Chemistry · doi:10.1021/jm00374a003 · Cited by 127
Heat Shock Protein 90 Inhibitors. A Text Book Example of Medicinal Chemistry?
Janin, Y. L. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050759r · Cited by 127
Self-citationPhetsuksiri, B., Baulard, A. R., Cooper, A. M., Minnikin, D. E., Douglas, J. D., Besra, G. S., & Brennan, P. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1042 · Cited by 127
Taking inventory: antibacterial agents currently at or beyond Phase 1
Bush, K., Macielag, M. J., & Weidner‐Wells, M. A. (2004) · Current Opinion in Microbiology · doi:10.1016/j.mib.2004.08.013 · Cited by 126
Anderson, D. H., Harth, G., Horwitz, M. A., & Eisenberg, D. S. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4461 · Cited by 126
Heerding, D. A., Chan, G., DeWolf, W. E., Fosberry, A. P., Janson, C. A., Jaworski, D. D., McManus, E. C., Miller, W. H., Moore, T. D., Payne, D. J., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00404-8 · Cited by 125
PS-15: a Potent, Orally Active Antimalarial from a New Class of Folic Acid Antagonists
Canfield, C. J., Milhous, W. K., Ager, A. L., Rossan, R. N., Sweeney, T. R., Lewis, N. J., & Jacobus, D. P. (1993) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1993.49.121 · Cited by 124
Multidrug Resistance of a Porin Deletion Mutant of Mycobacterium smegmatis
Stephan, J., Mailaender, C., Etienne, G., Daffé, M., & Niederweis, M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4163-4170.2004 · Cited by 123
Seward, H. E., Roujeinikova, A., McLean, K. J., Munro, A. W., & Leys, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607665200 · Cited by 122
Wehenkel, A., Fernandez, P., Bellinzoni, M., Catherinot, V., Barilone, N., Labesse, G., Jackson, M., & Alzari, P. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.046 · Cited by 121
TB drug discovery: addressing issues of persistence and resistance
Smith, C. V., Sharma, V., & Sacchettini, J. C. (2003) · Tuberculosis · doi:10.1016/j.tube.2003.08.019 · Cited by 121
Buynak, J. D. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.11.012 · Cited by 120
Cited by
Biological Activities of Hydrazone Derivatives
Rollas, S., & Küçükgüzel, S. G. (2007) · Molecules · doi:10.3390/12081910 · Cited by 1,220
Lilienkampf, A., Mao, J., Wan, B., Wang, Y., Franzblau, S. G., & Kozikowski, A. P. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900003c · Cited by 308
Raman, K., Yeturu, K., & Chandra, N. (2008) · BMC Systems Biology · doi:10.1186/1752-0509-2-109 · Cited by 280
Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis
Sacchettini, J. C., Rubin, E. J., & Freundlich, J. S. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1816 · Cited by 256
Sequential assembly of the septal cell envelope prior to V snapping in Corynebacterium glutamicum
Zhou, X., Rodriguez-Rivera, F. P., Lim, H. C., Bell, J. C., Bernhardt, T. G., Bertozzi, C. R., & Theriot, J. A. (2019) · Nature Chemical Biology · doi:10.1038/s41589-018-0206-1 · Cited by 61
Metadata
- Authors
- Janin, Y. L.
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 15
- Issue
- 7
- Pages
- 2479-2513
- ISSN
- 0968-0896 (ISSN-L)
- OpenAlex
- W1968397983
- Cited by
- 485
- References
- 377
- FWCI
- 26.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.